Back to results
US 2021/0341490 A1Published application
Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies
AssigneeAblynx N.V.
InventorsVeerle Snoeck, Marie-Ange Buyse, Judith Baumeister
Life of this patent
Estimating the term…
Abstract
Described herein are methods, assays and techniques for detecting and/or measuring anti-drug antibodies that bind to a protein, polypeptide or other compound or molecule that comprises at least one immunoglobulin variable domain with an exposed C-terminal region.
Claims15
Method for detecting and/or measuring anti-drug antibodies against a protein, polypeptide or other compound or molecule that comprises at least one immunoglobulin variable domain with an exposed C-terminal region in a sample, said method comprising at least the steps of:
- a) contacting said sample with a capturing agent that is immobilized on a support, wherein said capturing agent is or essentially consists of said protein, polypeptide or other compound or molecule, under conditions such that any anti-drug antibodies against said protein, polypeptide or other compound or molecule can bind to said capturing agent;
- b) (optionally) removing any components or constituents present in said sample that do not bind to the capturing agent;
- c) detecting or measuring any anti-drug antibodies that have bound to the capturing agent, by contacting the complex of the capturing agent and any captured anti-drug antibodies with a detection agent, under conditions such that said detection agent can bind to (the complex of the capturing agent and) any captured anti-drug antibodies,
- wherein either:
- x) said capturing agent is or essentially consists of:
- (i) said protein, polypeptide or other compound or molecule (immobilized on the solid support);
- and (ii) 1-5 amino acid residues that are linked to the exposed C-terminal end of the immunoglobulin variable domain with the exposed C-terminal region that is comprised within the protein, polypeptide or other compound or molecule;
- or:
- y) said detection agent is or essentially consists of:
- (i) said protein, polypeptide or other compound or molecule;
- (ii) a detectable tag or label bound to said protein, polypeptide or other compound or molecule (either directly or via a suitable linker) and (iii) 1-5 amino acid residues that are linked to the exposed C-terminal end of the immunoglobulin variable domain with the exposed C-terminal region that is comprised within the protein, polypeptide or other compound or molecule,
- in which said sample is a sample of whole blood, serum, plasma, ocular fluid, bronchoalveolar fluid/BALF, cerebrospinal fluid or other biological fluid.
9 more elements
(canceled)
Dependencies are inferred from the claim text.